We're excited to share the highly positive results from our NeVa CLEAR Study,* presented recently at the ESMINT annual meeting in Marseille, France, where we also celebrated the fifth anniversary of NeVa’s international commercialization. "The prospective CLEAR Study confirms the value and differentiation of the NeVa device compared to other stent retrievers for achieving rapid and effective revascularization," said Prof. Dr. Serdar Geyik, who presented the results at the ESMINT meeting on behalf of the CLEAR principal investigators. We're proud of this milestone. Click here to access the full press release: https://lnkd.in/gYbhS3-Z *The CLEAR Study, a prospective, multicenter, open-label, single-arm, FDA-regulated IDE trial, evaluated the safety and effectiveness of our #NeVa thrombectomy device in treating acute ischemic #stroke caused by large vessel occlusions (#LVO). NeVa is CE-approved and currently not available in the U.S. #NeVaFirstPass #DoTheDropZone #neurointervention #AIS #ESMINT2023 Diane Demet Tangun, Prof. Dr. Serdar Geyik, Nav Woodlands, Jennifer Geluso, Jessica Koradin, William von Brendel, MBA, MIM, Irene Haslinger, Hans-Juergen Bruns
关于我们
VESALIO is dedicated to advancing the care of patients suffering from vascular occlusion by providing physicians with superior technology designed to improve clinical outcomes. 26 strokes and 10 resulting deaths occur each minute due to vascular occlusion. VESALIO is driving innovation to improve care for patients in critical need and benefit the physicians that treat them. With NeVa(TM), enVast(TM), NeVa NET(TM), and NEVA VS (TM), VESALIO will continue to grow and innovate in the vascular intervention field. Follow us to stay updated on our activities and innovation.
- 网站
-
https://www.vesalio.com
Vesalio的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Nashville,Tennessee
- 类型
- 私人持股
- 创立
- 2017
- 领域
- thrombus clot removal technology、stent retriever、mechanical thrombectomy、Neurology、neurovascular、Neurosurgery、Cerebrovascular Diseases、interventional stroke treatment、endovascular procedures、Neuro Medical Device、NeuroTechnology、STEMI、stroke、AIS、vascular occlusion、Acute Ischemic Stroke、Vasospasm、CV post aSAH、Cardiovascular intervention和Neuro intervention
地点
-
主要
3200 West End Ave
Suite 500
US,Tennessee,Nashville,37203
Vesalio员工
-
William von Brendel, MBA, MIM
-
J.D. McCulloch, CFA, MBA
Chief Financial Officer, Vesalio
-
Bob Bushok
Vice President of Sales, Vesalio | Endovascular | Neurovascular | Thrombus | Stroke | Aneurysm | Vascular |…
-
Diane Demet Tangun
VP Market Development, MBA / International Marketing, Business Development, Commercialization in MedTech, Neuroradiology
动态
-
#DoTheDropZone in Lisbon! Vesalio looks forward to this week's #CIRSE2024 in Lisbon, Portugal. Find us at the #Stroke #thrombectomy hands-on training sessions in Hands-on Room 2: Session 1: Sunday Sept 15th, 13:00–14:30 - HDT-ST 24.4 Session 2: Sunday Sept 15th, 16:15–17:45 - HDT-ST 26.3 ?? #NeVa, for achieving impressive #FirstPassSuccess on ALL clot types ?? #NeVaNET, the world's first and only stent retriever equipped with clot microfiltration technology designed to maximize clot retention We hope to see you! NeVa & NeVa NET are CE-approved; not currently available in the U.S. #Stroke #AIS #LVO Diane Demet Tangun, Jessica Koradin, Irene Haslinger, Cardiovascular and Interventional Radiological Society of Europe
-
-
#ESMINT2024 was sensational! The engaging sessions, deepening connections, and hearing practitioners sharing their #FirstPassSuccess with #NeVa and #NeVaNET was inspiring! If we missed you, please get in touch with your local Vesalio representative to learn about: ?? #NeVa, for achieving impressive #FirstPassSuccess on ALL clot types ?? #NeVaNET, the world's first and only stent retriever equipped with clot microfiltration technology designed to maximize clot retention NeVa & NeVa NET are CE-approved; not currently available in the U.S. #Stroke #AIS #LVO Diane Demet Tangun, Jessica Koradin, Jennifer G.
-
-
-
-
-
+2
-
-
?? VESALIO Celebrated 6 years of Rocking Growth in Marseille?? On September 3, just before the kick-off of #ESMINT2024, the Vesalio team met with international sales partners in Marseille, France, for a dynamic time of discussing strategy, achievements, and upcoming Vesalio innovations in stroke treatment. Vesalio management unveiled the company's impressive outlook with an update on NeVa's and NeVa NET's growing market share and the outstanding #FirstPassSuccess physicians are experiencing worldwide. Success stories from across Europe took center stage. Special thanks to Dr. Ezequiel Petra for presenting his firsthand experiences with NeVa and NeVa NET, showing their real-life impact on stroke patients. Your contributions are advancing important innovations in stroke care. ?? Contact your local Vesalio rep to learn more about: ?? NeVa, leading the charge in #FirstPassSuccess across all clot types ?? NeVa NET, the world’s first and only stent retriever equipped with clot microfiltration technology designed for maximum clot retention We’re just getting started—stay tuned because, at Vesalio, we’re Rocking Now, Rocking Forever! ?? NeVa & NeVa NET are CE-approved; not currently available in the U.S. #Stroke #AIS #LVO Jessica Koradin, Diane Demet Tangun
-
-
??Announcing the launch of pVasc? Thrombectomy System for the safe and effective non-surgical removal of occlusions from the peripheral vasculature! ?? Get the details on #pVasc in today’s press release: https://lnkd.in/d4sEjGs3 When Complexity Requires Simplicity ?? #pVasc is FDA cleared for the removal of thrombi and emboli from peripheral vasculature and is not CE marked for this indication. #DoTheDropZone #PeripheralThrombectomy #AcuteLimbIschemia #interventionalradiology #VascularSurgery #PAD Dr. Frank Arko, Carolinas HealthCare System, Dr. Nick Abedi, Fayette Surgical Associates
-
-
Thanks for sharing this beautiful #enVast case, Dr árpád Lux, and for pioneering innovative technologies for better patient outcomes! #CoronaryThrombectomy
In August, we became one of the first centers in the Netherlands to perform thrombus retrievals using the enVast stent retriever. Our first patient had a significant thrombus burden in their right coronary artery. Together with Ralph Theunissen we successfully achieved TIMI III flow after just two applications. This innovative technology is helping us provide even better care to our patients. #MUMC #enVast #thrombectomy
-
-
#DoTheDropZone in Marseille! We've arrived at #ESMINT2024 in Marseille, France, and eagerly anticipate the upcoming sessions and opportunities to connect with friends and forge new connections in the #neurointervention space. Please visit our booth to say hello and hear the latest news on: ?? #NeVa, for achieving impressive #FirstPassSuccess on ALL clot types ?? #NeVaNET, the world's first and only stent retriever equipped with clot microfiltration technology designed to maximize clot retention Hope we see you soon! NeVa & NeVa NET are CE-approved; not currently available in the U.S. #Stroke #AIS #LVO Diane Demet Tangun, Jessica Koradin, Jennifer G.
-
-
Thanks for sharing this awesome case and for being so dedicated to advancing patient care, Dr Dario Bongiovanni! #enVast
On the way to the #ESC congress, thinking about yesterday's case of #STEMI with massive thrombotic burden. Still no place in the guidelines for coronary #thrombectomy. Is it time for new randomized trials? Thanks to Joel Reiling and Pablo Escrihuela Branz for the support!
-
-
#DoTheDropZone in Marseille! Vesalio eagerly awaits #ESMINT2024, 4-6 September, in beautiful Marseille, France. We always appreciate ESMINT's sessions, the opportunities to see friends & colleagues and forge new connections in the stimulating world of #neurointervention. Please mark your calendar to visit our booth and learn more about what we're up to, including news on: ?? #NeVa, for achieving impressive #FirstPassSuccess on ALL clot types ?? #NeVaNET, the world's first and only stent retriever equipped with clot microfiltration technology designed to maximize clot retention Hope we see you there! NeVa & NeVa NET are CE-approved; not currently available in the U.S. #Stroke #AIS #LVO Diane Demet Tangun, Jessica Koradin, Jennifer G.
-
-
Discover??#NeVaVS, the first and only FDA-approved device for post #aSAH #vasospasm. https://lnkd.in/gmUY5VRC For more NeVa VS info, contact Bob Bushok, Laura Hamilton, George Syndor, Ashley Monaco, Ken Dunaway, Kevin Mitchell NeVa VS is FDA-approved for the treatment of cerebral vasospasm due to aSAH and is not CE marked for this indication. #NeVaVS4Vasospasm #Neurointervention
Vesalio NeVa? VS Vasospasm Treatment Device 3D animation
https://www.youtube.com/